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ABSTRACT
Caprine herpesvirus type 1 (CpHV‐1), like other members of the alpha subfamily of herpesviruses, establishes latent infections in trigeminal
ganglion neurons. Our groups previously demonstrated that CpHV‐1 induces apoptosis in goat peripheral blood mononuclear cells and in an
epithelial bovine cell line, but the ability of CpHV‐1 to induce apoptosis in neuronal cells remains unexplored. In this report, the susceptibility of
Neuro 2A cells to infection by CpHV‐1 was examined. Following infection of cultured cells with CpHV‐1, expression of cell death genes was
evaluated using real‐time PCR and Western blot assays. Analysis of virus‐infected cells revealed activation of caspase‐8, a marker for the
extrinsic pathway of apoptosis, and caspase‐9, amarker for the intrinsic pathway of apoptosis at 12 and 24 h post‐infection. Signiﬁcant increase
in the levels of cleaved caspase‐3 was also observed at the acme of cytopathic effect at 24 h post‐infection. In particular, at 3 and 6 h post‐
infection, several proapototic genes were under‐expressed. At 12 h post‐infection several proapototic genes such as caspases, TNF, Cd70, and
Traf1 were over expressed while Bcl2a1a, Fadd, and TNF genes were underexpressed. In conclusion, the simultaneous activation of caspase‐8
and caspase‐9 suggests that CpHV‐1 can trigger the death‐receptor pathway and the mitochondrial pathway separately and in parallel. Our
ﬁndings are signiﬁcant because this is the ﬁrst published study showing the effect of CpHV‐1 infection in neuronal cells in terms of gene
expression and apoptosis modulation. J. Cell. Biochem. 114: 2809–2822, 2013.  2013 Wiley Periodicals, Inc.
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Apoptosis is an highly complex process regulated by a widerange of cell signals and eventually leading to DNA
fragmentation and cell demolition. Much insight has been gained
in recent years concerning the signalling pathways and the proteins
involved, but current models tend to attribute effects to the few
known complexes, and many key signalling players remain to be
elucidated [Lavrik, 2010].
Two major signalling cascades have been identiﬁed, namely the
extrinsic and intrinsic pathways [Krammer, 2000]. Both centrally
involve the caspase family of proteins as initiators and effectors of
apoptosis propagation [Lavrik et al., 2005]. Initiator caspases are, by
deﬁnition, the ﬁrst to be activated in the apoptotic pathway. They in
turn activate effector caspases, which trigger a series of proteolytic
events that eventually lead to cell death [Fuentes‐Prior and
Salvesen, 2004].
The extrinsic pathway is initiated when certain death receptors
(DR) on the cell surface are activated by death ligands (DL). DRmainly
comprise the tumour necrosis factor (TNF) receptor family including
FAS, TNFR1, and TRAIL (TNF‐related apoptosis‐inducing ligand)
receptor (activated by their respective DL such as FAS ligand, TNF,
and TRAIL) [Ashkenazi and Dixit, 1998]. Binding of a DL to a DR
results in death‐inducing signalling complex formation [Kischkel
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et al., 1995], which brings together the initiator caspases of the
extrinsic pathway, that is, procaspase‐8 and procaspase‐10 [Krammer
et al., 2007]. Cleavage of procaspase‐8 releases caspase‐8 into the
cytosol to act on effector caspases.
The intrinsic pathway is triggered by a variety of factors including
genotoxic stress, UV irradiation, certain hormones (e.g., glucocorti-
coids), and cytokine deprivation [Krammer et al., 2007]. Exposure to
these factors leads to mitochondrial outer membrane permeabilisa-
tion (MOMP) and eventually cytochrome c release from the
mitochondria into the cytosol [Green and Kroemer, 2004]. The
release of cytochrome c from the mitochondria is also regulated by
proteins of the B‐cell lymphoma 2 (Bcl‐2) family. The Bcl‐2 family is
divided into two classes of molecules that have opposing effects:
antiapoptotic members such as Bcl‐2 and Bcl‐xL that protect the cell
against apoptosis, and proapoptotic members such as Bcl‐2‐
associated X protein (Bax) and Bcl‐2 homologous antagonist/killer
(Bak) that trigger apoptosis. The apoptosome formed between released
cytochrome c, apoptosis‐activating factor 1 and caspase‐9 recruits
and activates the initiator caspase of the intrinsic pathway,
procaspase‐9. Cleavage of procaspase‐9 liberates caspase‐9, which
in turn activates downstream effector caspases [Brenner and Mak,
2009].
A ﬁnal common pathway for both intrinsic and extrinsic cascades
involves activation of the effector caspases (caspase‐3, caspase‐6,
and caspase‐7) by caspase‐8 in the extrinsic pathway or caspase‐9 in
the intrinsic pathway. This then triggers cleavage of cellular proteins,
nuclear shrinkage, and DNA fragmentation [Krammer et al., 2007; Lo
et al., 2011].
Among stimuli that have been associated with apoptosis are
infections with mammalian DNA and RNA viruses [Hay and
Kannourakis, 2002]. Viruses possess various biochemical and genetic
mechanisms to evade and/or induce apoptosis in infected cells
through interactions at different stages of the apoptotic pathway and
it has been demonstrated that apoptosis modulation through virus‐
encoded proteins is a key step in herpesviruses pathogenesis
[Henderson et al., 1993; Hu et al., 1997; Wang et al., 1997; Cassady
et al., 1998; Pagnini et al., 2004; Pagnini et al., 2005; Marfè et al.,
2006; Longo et al., 2009].
Apoptotic phenomenon has been observed after infections with
herpes simplex virus (HSV) type 2 (in the brain) [Geiger et al.,
1995], varicella‐zoster virus (in cultured cells) [Sadzot‐Delvaux
et al., 1995; Brazeau et al., 2010], and CpHV‐1 (in blood mononuclear
cells) [Pagnini et al., 2005]. Moreover, several herpesvirses such as
HSV, VZV, and EHV‐1 show a marcked neurotropism and neuro-
virulence [Watanabe et al., 2000; Pugazhenthi et al., 2011; Mori et al.,
2012].
Caprine Herpesvirus 1 (CpHV‐1) belongs to the Alphaherpesvirinae
subfamily and show genomic similarity to other viruses of this group,
such as Bovine Herpesvirus 1 (BoHV‐1), the etiological agent of IBR/
IPV, Bovine Herpesvirus 5 (BoHV‐5), Suid Herpesvirus 1 (SuHV‐1),
Cervid Herpesvirus 1, and Rangiferine Herpesvirus 1 [Thiry et al.,
2006]. Caprine Herpesvirus 1, is associated with two different
syndromes in goats, depending on the age of the animals at the time
of infection. In young kids, CpHV‐1 causes an often generalized
disease mainly affecting the digestive tract [Saito et al., 1974; Mettler
et al., 1979; Roperto et al., 2000]. Infection in adult goats remains
unapparent, or may cause respiratory distress, abortion [Berrios et al.,
1975; Waldvogel et al., 1981; Williams et al., 1997], vulvovaginitis or
balanoposthitis [Horner et al., 1982; Tisdall et al., 1984]. Moreover,
being a member of alphaherpesvirus, CpHV‐1 is able to establish
latent infection in trigeminal ganglia [Plebani et al., 1983;
Buonavoglia et al., 1996] and to cause immunosuppression [Pagnini
et al., 2005]. Thus, CpHV‐1 infection is responsible for severe
economic losses due to abortions, stillbirths, reproductive disorders,
and susceptibility of CpHV‐1‐infected host to secondary bacterial
infections.
Like herpes simplex virus 1 (HSV‐1), the prototype member of
the alpha subfamily of herpesviruses, CpHV‐1 establishes life‐long,
non‐productive latent infections in ganglionic sensory neurons
(Homan and Easterday, 1980; Jones, 1998; Delhon et al., 2002).
During the ﬁrst days following infection by herpesviruses, some
neurons are productively infected (acute phase). However, other
neurons are not permissive to virus replication and become
latently infected. After the acute phase subsides, these cells
continue to harbour viral DNA without producing infectious virus
(latent phase). During latency, gene expression is restricted to a
small region of the genome known as the latency‐related (LR)
or latency‐associated region [Rock et al., 1987; Stevens et al.,
1987].
Our group previously showed that CpHV‐1 is able to induce
apoptosis in goat peripheral blood mononuclear cells [Pagnini
et al., 2005] and we investigated on the pro‐apoptotic potential
of CpHV‐1 in a permissive cell line (Madin Darby bovine kidney
cells), evaluating apoptotic proﬁles like chromatin condensation
and DNA laddering [Longo et al., 2009]. In this report, to characterize
in more detail the intracellular pathway by which CpHV‐1 is able
to induce apoptosis, we have analyzed the gene expression response
during the apoptotic phase of CapHV‐1 infection in a neuronal
cell line.
MATERIALS AND METHODS
CELLS AND VIRUS
Mouse Albino Neuroblastoma (Neuro 2A) cells (CCL‐131, American-
Type Culture Collection) were grown in Dulbecco0s modiﬁed minimal
essential medium (DMEM), supplemented with 100 IU/ml of penicil-
lin, 100mg/ml of streptomycin, and 5% pestivirus free foetal calf
serum. This cell line was maintained free of mycoplasma and of
bovine viral diarrhoea virus.
The reference Swiss strain E/CH [Mettler et al., 1979] of CpHV‐1
was used. It was multiplied on MDBK, and cell extracts, obtained by
three cycles of freezing and thawing, were pooled, collected, and
stored in aliquots at 80°C. Infectivity titers were expressed as
median tissue culture infectious doses (TCID50)/ml [Reed and
Muench, 1938].
APOTOX‐GLO™TRIPLEX ASSAY
The ApoTox‐Glo™Triplex assay was used in order to assess
viability, cytotoxicity, and caspase activation events within a
single assay well. In the ﬁrst part of the assay, it measures
two protease activities simultaneously; one being a marker of cell
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viability and the other being a marker of cytotoxicity. Peptide
substrate (glycylphenylalanyl‐aminoﬂuoro‐coumarin; GF‐AFC) en-
ters intact cells where it is cleaved by the live‐cell protease activity to
generate a ﬂuorescent signal proportional to the number of living
cells. This live‐cell protease becomes inactive upon loss of cell
membrane integrity and leakage into the surrounding culture
medium. Peptide substrate (bis‐alany‐lalanyl‐phenylalanyl‐rhoda-
mine 110; bis‐AAF‐R110) is used to measure dead‐cell protease
activity, which is released from cells that have lost membrane
integrity. Bis‐AAF‐R110 is not cell‐permeable, so no signal from this
substrate is generated by intact, viable cells. The live‐ and dead‐cell
proteases produce different products, AFC and R110, which have
different excitation and emission spectra, allowing them to be
detected simultaneously. In the second part of the assay, the Caspase‐
Glo® 3/7 Reagent, added in an “add‐mix‐measure” format, results in
cell lysis, followed by caspase cleavage of the substrate and
generation of a “glow‐type” luminescent signal produced by
luciferase.
Neuro 2A cells of approximately 500/well were seeded in a ﬂat 96‐
well micro‐plate (Becton Dickinson Labware, USA) as triplicates. Four
different types of controls, namely: positive, infected, negative, and
background controls were used throughout the study. Positive control
had cells with culture medium treated with Staurosporine of 10mM
ﬁnal concentration for 3, 6, 12, 24, and 48 h to induce apoptosis.
Infected cell cultures contained cells treated with CapHV‐1 at MOI 1
for 3, 6, 12, 24, and 48 h. Negative control consisted of mock infected
Neuro 2A cells and no‐cell control (background) containing only
culture medium without cells [Pelzl et al., 2009].
After 3, 6, 12, 24, and 48 h post‐infection 20ml of viability/
cytotoxicity reagent containing both GF‐AFC and bis‐AAF‐R110
substrates was added to each well and brieﬂy mixed by orbital
shaking at 300–500 rpm for 30 s and then incubated at 37°C for 30–
180min. Fluorescence was measured at 400Ex/505Em (Viability) and
485Ex/520Em (Cytotoxicity) by using Glomax Multi Detection
System multiwell plate reader (Promega Corporation, USA). After
that 100ml of Caspase‐Glo 3/7 reagent was added to each well,
and brieﬂy mixed by orbital shaking at 300–500 rpm for 30 s and
then incubated at room temperature for 30–180min. Luminescence
was measured using a Glomax Multi Detection System multiwell
plate reader (Promega Corporation, USA) by Luminiscence
protocol which is proportional to the amount of caspase activity
present.
VERIFICATION OF APOPTOTIC GENE EXPRESSION PROFILING OF
CPHV‐1‐INFECTED NEURO 2A CELLS BY QUANTITATIVE REAL‐TIME
PCR
The RT2 qPCR proﬁler Mouse Signal Transduction Pathway array
(catalog number PAMM‐012, SABiosciences, Frederick, MD), repre-
senting 84 genes involved in signal transduction pathways, plus ﬁve
housekeeping genes and three controls, was used to analyze the effect
of CpHV‐1 infection on signaling‐related gene expression in Neuro
2A cell line. The total RNA was isolated from the infected (MOI 1) and
mock infected cells cultures using the Rneasy Mini Kit (Qiagen), at 3,
6, 12, 24, and 48 h post‐infection. cDNA was generated from 1mg
total RNA using the RT2qPCR Array First Strand Kit in accordance
with manufacturer0s instructions. The template was combined with
RT2 SYBR Green/Fluorescein PCR master mix. Equal amounts of this
mixture (25ml) were added to each well of the RT2qPCR proﬁler plate
containing the predispensed gene‐speciﬁc primer sets, and the
reaction was performed using StepOnePlus (Applied Biosystems)
according to the manufacturer0s protocols.
Data analysis was based on the DDCt method with the aid of an
Excel (Microsoft Excel; Microsoft, Redmond, WA) spreadsheet
containing algorithms provided by themanufacturer (RT2ProﬁlerPCR
Array data Analysis software http://pcrdataanalysis.sabiosciences.
com/pcr/arrayanalysis.php).
The expression levels of the mRNA of each gene were normalized
using the expression of the housekeeping gene GAPDH. A positive
value indicates that the gene was upregulated and a negative value
indicates that the gene was downregulated.
PROTEIN EXTRACTION AND WESTERN BLOT ANALYSIS
Sodium dodecyl sulphate polyacrylamide gel electrophoresis and
Western blot analysis were performed on CpHV‐1 infected Neuro 2A
cells and on mock infected Neuro 2A cells.
Neuro 2A cells in 75 cm2 ﬂask, at conﬂuency, were infected with
CpHV‐1 at MOI 1. At 3, 6, 12, 24, and 48 h post‐infection, adherent
cells were washed twice with PBS and scraped.
Cells were then mixed with cells previously collected by
centrifugation from supernatant of the same ﬂask and resuspended
in PBS. The pellets, obtained by centrifugation, were stored at 20°C
and then processed by Western blot analysis as previously
described [Montagnaro et al., 2013]. To measure caspases
activation at least 1 106 cells were used. Cells were
homogenized directly into lysis buffer 50mM Tris pH 7.5; 150mM
NaCl; 1mM EDTA; 0.25% deoxycholic acid, 1% Triton X‐100)
with 20mM sodium pyrophosphate, 0.1mg/mL aprotinin, 2mM
phenylmethylsulphony ﬂuoride (PMSF), 10mM sodium orthovana-
date (Na2VO3), and 50mM sodium ﬂuoride (NaF). Protein concen-
trations were determined by use of a protein assay kit (Bio‐Rad
Laboratories).
Equal amounts of lysate samples were boiled and loaded on bis/
acrylamide gels, separated by electrophoresis and proteins were
blotted from the gel onto nitrocellulose membranes. The membranes
were blocked with 5% bovine serum albumin (BSA) in tris buffered
saline (TBS: 12.5mM Tris–HCl pH 7.4; 125mM NaCl) at room
temperature, washed with TBS‐0.1% Tween and incubated with
primary antibody.
The primary antibodies used were rabbit anti‐cleaved caspase 3
(Cell Signaling Technologies catalog no. 9662; 1:1,000 diluition), or
rabbit anti‐caspase 8 p18 (Santa Cruz Biotechnology, Santa Cruz, CA;
catalog no. sc‐7890; 1:200 dilution), rabbit anti‐caspase 9 (Santa
Cruz Biotechnology, Santa Cruz, CA; catalog no. sc‐8355; 1:200
dilution), rabbit anti‐Bcl2 (Abcam plc, Cambridge, UK; catalog no.
ab7973; 1:100 diluition); rabbit anti‐phospho‐Bcl2 (Cell Signaling
Technologies catalog no. 2827; 1:1,000 diluition), mouse anti‐p53
(Santa Cruz Biotechnology, Santa Cruz, CA; catalog no. sc‐99; 1:200
dilution), rabbit anti‐phospho‐p53 (Cell Signaling Technologies,
catalog no. 2528; 1:1,000 diluition).
After appropriate washing steps, peroxidase‐conjugated anti‐
rabbit IgG (GE Healtcare, UK, catalog no. NA934) or anti‐mouse
IgG (GE Healtcare, UK, catalog no. NA931) was applied for 1 h at
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a 1:1,000 dilution. The blots were stripped and reprobed against
mouse anti‐actin antibody (Calbiochem, San Diego, CA; catalog no.
CP10) at 1:5,000 dilution to conﬁrm equal loading of proteins in
each lane. Protein expression levels were quantitatively estimated by
densitometry using a Gel Doc scanner (BioRad) equipped with a
densitometric workstation. The protein concentrations were normal-
ized to the actin level and expressed as relative band density
(arbitrary units).
Fig. 1. CpHV‐1 induce apoptosis in Neuro 2A cells. Replicate cultures of Neuro 2A cells were mock infected or infected with inoculum consisting of criolysated infected Neuro 2A
cells. Inoculum had been titrated in advance, and the multiplicity of infection was approximately 1. At different time points after infection, the viability, cytotoxicity, and apoptosis
were assayed using ApoTox‐Glo™Triplex assay. Results are expressed as Relative Fluorescence Units (RFU) and Relative Luminescence Units (RLU) and reported as the mean SD of
three separate experiments. A P‐value <0.05 was selected as signiﬁcant.
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STATISTICAL ANALYSIS
The results are presented as mean SD of three experiments. One‐
way ANOVA with Turkey0s post‐test was performed using GraphPad
InStat Version 3.00 forWindows 95 (GraphPad Software, San Diego,
CA). P‐value <0.05 was considered statistically signiﬁcant.
RESULTS
APOTOX‐GLO™TRIPLEX ASSAY
In a ﬁrst series of experiment we have analysed the effect of CpHV‐1
infection on cytotoxicity, viability, and apoptosis within a single
assay well, by using the ApoTox‐Glo™Triplex assay.
The graphs in Figure 1 depicts the results of an ApoTox‐
Glo™Triplex assay showing the cytotoxicity, viability, and apoptosis
of Neuro 2A cells infected with CpHV‐1 at MOI 1.
After 24 and 48 h post‐infection, the cytotoxicity of CpHV‐1
infected cells, compared to the mock infected cells, increased
signiﬁcantly in a time dependent manner (Fig. 1B).
The graph in Figure 1A depicts the results of an Apo‐Tox‐Glo™
Triplex assay showing the viability of Neuro 2A cells infected with
CpHV‐1 at MOI 1. After 24 and 48 h post‐infection, the viability
CpHV‐1 infected cells signiﬁcantly decreased respect to untreated
control cells.
The Figure 1C show the results of an Apo‐Tox‐Glo™ Triplex assay
showing the activation of caspase 3 in Neuro 2A cells infected with
CpHV‐1 at MOI 1 at 3, 6, 12, 24, and 48 h post‐infection. CpHV‐1
infected cells showed high level of caspase 3 at 24 and 48 h post‐
infection respect to mock infected control cells.
VERIFICATION OF APOPTOTIC GENE EXPRESSION PROFILING OF
CPHV‐1‐INFECTED NEURO 2A CELLS BY QUANTITATIVE REAL‐TIME
PCR
To detect the apoptotic genes involved in CpHV‐1‐induced apoptosis,
we scanned 84 apoptosis genes by RT2 Proﬁler PCR microarray
(Tables I–V). A wide spectrum of apoptosis‐relavant genes was
upregulated and downregulated during CpHV‐1 infection.
TABLE I. Genes Over‐ and Under‐Expressed at 3 h Post‐Infection by CpHV‐1
Symbol Description
Fold
change Symbol Description Fold change
Cradd CASP2 and RIPK1 domain containing adaptor
with death domain
5.5644 Xiap X‐linked inhibitor of apoptosis 4.0695
Abl1 C‐abl oncogene 1, non‐receptor tyrosine kinase 3.8019 Cd40 CD40 antigen 5.5257
Aifm1 Apoptosis‐inducing factor,
mitochondrion‐associated 1
7.3549 Cidea CD40 ligand 2.2402
Akt1 Thymoma viral proto‐oncogene 1 6.3038 Dad1 Cell death‐inducing DNA fragmentation factor,
alpha subunit‐like effector A
2.6346
Apaf1 Apoptotic peptidase activating factor 1 9.9738 Dapk1 Death associated protein kinase 1 7.7399
Api5 Apoptosis inhibitor 5 4.2568 Dffb DNA fragmentation factor, beta subunit 3.18
Atf5 Activating transcription factor 5 2.6639 Diablo Diablo homolog (Drosophila) 7.7399
Bag1 Bcl2‐associated athanogene 1 3.3355 Fadd Fas (TNFRSF6)‐associated via death domain 3.6342
Bag3 Bcl2‐associated athanogene 3 4.1664 Fas Fas (TNF receptor superfamily member 6) 2.9981
Bak1 BCL2‐antagonist/killer 1 8.8519 Fasl Fas ligand (TNF superfamily, member 6) 17.0168
Bax Bcl2‐associated X protein 3.2272 Lhx4 LIM homeobox protein 4 7.6796
Bcl10 B‐cell leukemia/lymphoma 10 4.7136 Mapk1 Mitogen‐activated protein kinase 1 7.6803
Bcl2 B‐cell leukemia/lymphoma 2 17.6559 Mcl1 Myeloid cell leukemia sequence 1 7.205
Bcl2a1a B‐cell leukemia/lymphoma 2 related protein A1a 2.6827 Naip2 NLR family, apoptosis inhibitory protein 2 8.527
Bcl2l1 Bcl2‐like 1 3.1334 Nme5 Non‐metastatic cells 5, protein expressed in
(nucleoside‐diphosphate kinase)
4.5562
Bcl2l10 Bcl2‐like 10 5.7487 Nod1 Nucleotide‐binding oligomerization domain
containing 1
4.8126
Birc3 Baculoviral IAP repeat‐containing 3 4.8778 Nol3 Nucleolar protein 3 (apoptosis repressor with
CARD domain)
2.3031
Birc5 Baculoviral IAP repeat‐containing 5 5.4074 Polb Polymerase (DNA directed), beta 7.7399
Bnip2 BCL2/adenovirus E1B interacting protein 2 192.3201 Prdx2 Peroxiredoxin 2 2.2155
Bnip3 BCL2/adenovirus E1B interacting protein 3 7.7399 Pycard PYD and CARD domain containing 7.0338
Bnip3l BCL2/adenovirus E1B interacting protein 3‐like 23.202 Ripk1 Receptor (TNFRSF)‐interacting serine‐threonine
kinase 1
4.3588
Bok BCL2‐related ovarian killer protein 9.2989 Tnf Tumor necrosis factor 3.1233
Card10 Caspase recruitment domain family, member 10 2.0503 Tnfrsf11b Tumor necrosis factor receptor superfamily,
member 11b (osteoprotegerin)
3.6758
Casp1 Caspase 1 7.8312 Tnfrsf1a Tumor necrosis factor receptor superfamily,
member 1a
25104851.5815
Casp12 Caspase 12 3.2708 Tnfsf10 Tumor necrosis factor (ligand) superfamily,
member 10
3.538
Casp14 Caspase 14 2.1739 Tnfsf12 Tumor necrosis factor (ligand) superfamily,
member 12
3.1993
Casp2 Caspase 2 2.3658 Traf1 Tnf receptor‐associated factor 1 7.7399
Casp3 Caspase 3 7.7399 Traf2 Tnf receptor‐associated factor 2 9.2416
Casp4 Caspase 4 3.247 Traf3 Tnf receptor‐associated factor 3 3.3477
Casp7 Caspase 7 7.7399 Trp53bp2 Transformation related protein 53 binding protein
2
13.3396
Casp8 Caspase 8 9.3871 Trp73 Transformation related protein 73 3.1029
Casp9 Caspase 9 2.2536
Regulated genes with fold change 2.0 (either up or down) and P‐values of 0.05 are presented, expressed in Neuro 2A cell line infected with CpHV‐1 (MOI 1) at 3 h post‐
infection are presented.
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In particular, at 3 h post‐infection, several proapototic genes such
as Fas, Fadd, TNF, and caspase were under‐expressed (Table I).
Starting from 6h post‐infection Fas and TNF genes resulted to be
over‐expressed (Table II). At 12 h post‐infection several proapototic
genes like caspase (1, 3, 4, 6, 7, 8, 10, 12, 14,) TNF, Cd70, and Traf1
were over expressed. Conversely, at 12 h post‐infection Bcl2a1a,
Fadd, and TNF genes were underexpressed (see Table III). After 24 and
48 h post‐infectionmany genes were up and down regulated probably
due to the massive citopatyc effect (see Tables IV and V).
PROTEIN EXTRACTION AND WESTERN BLOT ANALYSIS
To investigate the modulation of apoptotic pathway in Neuro 2A
infected with CpHV‐1, we also measured the apoptotic protein
expression by Western blot analysis.
Activation of the DNase responsible for oligonucleosomal
degradation of nuclear chromatin is dependent on cleavage of an
inhibitor complexed with the DNase molecule [Sakahira et al., 1998].
The cleavage is mediated by caspase‐3, which in turn is activated by
either initiator caspase‐8 or caspase‐9. Caspase‐8 and caspase‐9
represent the extrinsic and intrinsic pathways of apoptosis cascade
triggering, respectively.
In order to characterize the pathway that triggers the apoptotic
cascade during CpHV‐1 infection, we examined cleavage of caspase‐
8 and caspase‐9 in samples of mock‐ and CpHV‐1‐infected Neuro 2A
cells collected at 3, 6, 12, 24, and 48 h post‐infection by the use of
Western blotting and caspase‐speciﬁc antibodies. Western blot
analysis showed signiﬁcant changes in the amounts of caspase 8 at
24 h post‐infection (Fig. 2A,B). In fact, we have observed, at the same
time, a 18‐kDa protein band corresponding to the processed form of
caspase‐8 that is detected by the same antibody. Similarly, the
appearance of a 37‐kDa protein corresponding to the cleaved form of
caspase‐9 was observed starting at 24 h p.i. (Fig. 2A,C). Once
processed, caspase‐9 further cleaves procaspase‐3, activating
caspase‐3. A cleaved caspase‐3 fragment corresponding to the 17‐
kDa protein bandwas detected starting at 12 h post‐infection (Fig. 2A,
D), whit an acme at 24 h post‐infections.
In CpHV‐1‐infected Neuro 2A cells the expression of Bcl2 and
phospho‐Bcl2 was signiﬁcantly increased at 12 and 24 in time
dependent manner (Fig. 3). We also tested p53 and phospho‐p53
expression in CpHV‐1‐infected and mock infected Neuro 2A cells. At
24 h post‐infection p53 was signiﬁcantly increased, while phospho‐
p53 increased starting from 3h post‐infection with an acme at 12 h
post‐infection (Fig. 4).
DISCUSSION
Apoptosis or programmed cell death is an encoded suicide
program that allows the elimination of cells that have been
produced in excess, developed improperly, or sustained genetic
damage.
Several viruses trigger apoptosis in infected cells at an early stage
of infection when virus particles interact with receptors on the cell
surface or at the time of fusion with cell membrane and disassembly
TABLE II. Genes Over‐ and Under‐Expressed at 6 h Post‐Infection by CpHV‐1
Symbol Description
Fold
change Symbol Description
Fold
change
Fasl Fas (TNF receptor superfamily member 6) 6.4839 Nol3 Nucleotide‐binding oligomerization domain containing 1 2.1385
Tnf Tumor necrosis factor 2.233
Abl1 C‐abl oncogene 1, non‐receptor tyrosine kinase 2.9488 Dad1 Cell death‐inducing DNA fragmentation factor, alpha
subunit‐like effector A
10.4774
Aifm1 Apoptosis‐inducing factor,
mitochondrion‐associated 1
5.7699 Dffa DNA fragmentation factor, alpha subunit 19.7952
Akt1 Thymoma viral proto‐oncogene 1 6.4817 Fadd Fas (TNFRSF6)‐associated via death domain 5.6866
Api5 Apoptosis inhibitor 5 2.4396 Fas Fas (TNF receptor superfamily member 6) 11.8323
Atf5 Activating transcription factor 5 4.4826 Gadd45a Growth arrest and DNA‐damage‐inducible 45 alpha 2.009
Bag1 Bcl2‐associated athanogene 1 2.3089 Il10 Interleukin 10 3.9316
Bak1 BCL2‐antagonist/killer 1 2.6708 Lhx4 LIM homeobox protein 4 5.7746
Bcl2 B‐cell leukemia/lymphoma 2 3.1533 Ltbr Lymphotoxin B receptor 2.4825
Bcl2a1a B‐cell leukemia/lymphoma 2 related protein A1a 3.4393 Mapk1 Mitogen‐activated protein kinase 1 11.6602
Bcl2l10 Bcl2‐like 10 6.9293 Naip2 NLR family, apoptosis inhibitory protein 2 2.2603
Bcl2l11 BCL2‐like 11 (apoptosis facilitator) 6.5965 Nfkb1 Nuclear factor of kappa light polypeptide gene enhancer in
B‐cells 1, p105
4.5239
Bcl2l2 Bcl2‐like 2 5.9661 Nod1 Nucleotide‐binding oligomerization domain containing 1 6.7005
Bid Bcl2‐like 1 2.5608 Prdx2 Peroxiredoxin 2 3.2921
Birc2 Baculoviral IAP repeat‐containing 2 66.5446 Pycard PYD and CARD domain containing 13.4001
Birc3 Baculoviral IAP repeat‐containing 3 16.7838 Ripk1 Receptor (TNFRSF)‐interacting
serine‐threonine kinase 1
2.798
Birc5 Baculoviral IAP repeat‐containing 5 20.4182 Tnfrsf10b Tumor necrosis factor receptor superfamily, member 10b 38.9134
Bnip2 BCL2/adenovirus E1B interacting protein 3 5916.5031 Tnfrsf11b Tumor necrosis factor receptor superfamily, member 11b
(osteoprotegerin)
3.8718
Bnip3l BCL2/adenovirus E1B interacting protein
3‐like
20.6852 Tnfsf12 Tumor necrosis factor (ligand) superfamily, member 12 2.5211
Bok BCL2‐related ovarian killer protein 3.7808 Traf3 Tnf receptor‐associated factor 3 2.2858
Card10 Caspase recruitment domain family, member 10 2.5367 Trp53 Transformation related protein 53 24.684
Casp6 Caspase 6 5.4272 Trp63 Transformation related protein 63 3.9655
Casp8 Caspase 8 16.4795 Trp73 Transformation related protein 73 49.0112
Cidea CD40 ligand 3.1964 Xiap X‐linked inhibitor of apoptosis 6.1029
Regulated genes with fold change 2.0 (either up or down) and P‐values of 0.05 are presented, expressed in Neuro 2A cell line infected with CpHV‐1 (MOI 1) at 6 h
post‐infection are presented.
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TABLE III. Genes Over‐ and Under‐Expressed at 12 h Post‐Infection by CpHV‐1
Symbol Description
Fold
change Symbol Description
Fold
change
Abl1 C‐abl oncogene 1, non‐receptor tyrosine kinase 2.5434 Cd70 CD70 antigen 10.4642
Anxa5 Annexin A5 11.706 Cideb Cell death‐inducing DNA fragmentation factor, alpha
subunit‐like effector B
3.1213
Apaf1 Apoptotic peptidase activating factor 1 2.1478 Cradd CASP2 and RIPK1 domain containing adaptor with death
domain
6.7399
Bad BCL2‐associated agonist of cell death 2.0824 Dapk1 Death associated protein kinase 1 13.4782
Bag3 Bcl2‐associated athanogene 3 3.2227 Dffa DNA fragmentation factor, alpha subunit 2.1903
Bax Bcl2‐associated X protein 5.2575 Dffb DNA fragmentation factor, beta subunit 5.8786
Bcl10 B‐cell leukemia/lymphoma 10 13.4782 Diablo Diablo homolog (Drosophila) 13.4782
Bcl2l1 Bcl2‐like 1 4.2583 Fasl Fas ligand (TNF superfamily, member 6) 3.5359
Bcl2l2 Bcl2‐like 1Bcl2‐like 2 9.147 Gadd45a Growth arrest and DNA‐damage‐inducible 45 alpha 3.4116
Bnip2 BCL2/adenovirus E1B interacting protein 2 13.4782 Igf1r Insulin‐like growth factor I receptor 10.4614
Bnip3 BCL2/adenovirus E1B interacting protein 2 13.4782 Il10 Interleukin 10 2.7443
Bnip3l BCL2/adenovirus E1B interacting protein 3‐like 4.2965 Mcl1 Myeloid cell leukemia sequence 1 8.6676
Bok BCL2‐related ovarian killer protein 8.6406 Naip2 NLR family. apoptosis inhibitory protein 2 5.6412
Card10 Caspase recruitment domain family, member 10 3.5986 Polb Polymerase (DNA directed), beta 13.4782
Casp1 Caspase 1 13.4782 Tnfrsf10b Tumor necrosis factor receptor superfamily, member 10b 2.9891
Casp12 Caspase 12 4.7559 Tnfrsf11b Tumor necrosis factor receptor superfamily, member 11b
(osteoprotegerin)
4.381
Casp14 Caspase 14 3.596 Tnfrsf1a Tumor necrosis factor receptor superfamily, member 1a 8.3783
Casp3 Caspase 3 13.4782 Tnfsf10 Tumor necrosis factor (ligand) superfamily, member 10 2.2295
Casp4 Caspase 4 13.4782 Tnfsf12 Tumor necrosis factor (ligand) superfamily, member 12 2.1111
Casp6 Caspase 6 5.7523 Traf1 Tnf receptor‐associated factor 1 13.4782
Casp7 Caspase 7 13.4782 Traf2 Tnf receptor‐associated factor 2 2.4416
Casp8 Caspase 8 4.0298 Trp63 Transformation related protein 63 2.2063
Cd40 CD40 antigen 8.4609
Bcl2a1a B‐cell leukemia/lymphoma 2 related protein A1a 2.3584 Fadd Fas (TNFRSF6)‐associated via death domain 3.5719
Tnf Tumor necrosis factor 3.5503
Regulated genes with fold change2.0 (either up or down) and P‐values of0.05 are presented, expressed in Neuro 2A cell line infected with CpHV‐1 (MOI 1) at 12 h post‐
infection are presented.
TABLE IV. Genes Over‐ and Under‐Expressed at 24 h Post‐Infection by CpHV‐1
Symbol Description
Fold
change Symbol Description
Fold
change
Xiap X‐linked inhibitor of apoptosis 4.0695
Aifm1 Apoptosis‐inducing factor, mitochondrion‐
associated 1
15.9044 Dad1 Defender against cell death 1 3.2977
Akt1 Thymoma viral proto‐oncogene 1 3.1839 Dffb DNA fragmentation factor, beta subunit 2.6608
Api5 Apoptosis inhibitor 5 14.4781 Fadd Fas (TNFRSF6)‐associated via death domain 10.5391
Atf5 Activating transcription factor 5 2.1774 Fas Fas (TNF receptor superfamily member 6) 17.8168
Bad BCL2‐associated agonist of cell death 3.938 Fasl Fas ligand (TNF superfamily, member 6) 60.2972
Bag1 Bcl2‐associated athanogene 1 6.3526 Gadd45a Growth arrest and DNA‐damage‐inducible 45 alpha 4.0851
Bag3 Bcl2‐associated athanogene 3 6.6082 Igf1r Insulin‐like growth factor I receptor 10.0671
Bak1 BCL2‐antagonist/killer 1 37.8345 Il10 Interleukin 10 11.7901
Bcl2 B‐cell leukemia/lymphoma 2 19.0913 Lhx4 LIM homeobox protein 4 5.8171
Bcl2l10 Bcl2‐like 10 32.9371 Ltbr Lymphotoxin B receptor 7.3538
Bcl2l11 BCL2‐like 11 (apoptosis facilitator) 6.8497 Mapk1 Mitogen‐activated protein kinase 1 5.0789
Bcl2l2 Bcl2‐like 2 2.4005 Naip1 NLR family, apoptosis inhibitory protein 1 13.7733
Bid BH3 interacting domain death agonist 7.3919 Naip2 NLR family, apoptosis inhibitory protein 2 4.0633
Birc2 Baculoviral IAP repeat‐containing 2 3.1317 Nod1 Nucleotide‐binding oligomerization domain containing 1 107.9962
Birc3 Baculoviral IAP repeat‐containing 3 19.8521 Polb Polymerase (DNA directed), beta 2.209
Birc5 Baculoviral IAP repeat‐containing 5 2.0833 Prdx2 Peroxiredoxin 2 11.77
Bnip3l BCL2/adenovirus E1B interacting protein 3‐like 9.7815 Pycard PYD and CARD domain containing 39.7069
Bok BCL2‐related ovarian killer protein 101.9957 Ripk1 Receptor (TNFRSF)‐interacting serine‐threonine kinase 1 12.1399
Card10 Caspase recruitment domain family, member 10 2.3448 Tnfrsf11b Tumor necrosis factor receptor superfamily, member 11b
(osteoprotegerin)
3.0839
Casp2 Caspase 2 4.3444 Tnfsf12 Tumor necrosis factor (ligand) superfamily, member 12 7.3892
Casp6 Caspase 6 2.7112 Traf2 Tnf receptor‐associated factor 2 4.7817
Casp8 Caspase 8 6.6039 Traf3 Tnf receptor‐associated factor 3 2.9862
Casp9 Caspase 9 4.2025 Trp53 Transformation related protein 53 2.0039
Cd40lg CD40 ligand 5.9645 Trp53bp2 Transformation related protein 53 binding protein 2 30.856
Cideb Cell death‐inducing DNA fragmentation factor,
alpha subunit‐like effector B
3.5427 Trp63 Transformation related protein 63 9.5018
Cradd CASP2 and RIPK1 domain containing adaptor
with death domain
2.7054
Regulated genes with fold change2.0 (either up or down) and P‐values of0.05 are presented, expressed in Neuro 2A cell line infected with CpHV‐1 (MOI 1) at 24 h post‐
infection are presented.
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[Ramsey‐Ewing and Moss, 1998; Jan et al., 2000; Barton et al., 2001;
Connolly and Dermody, 2002; Bok et al., 2009]. In addition, certain
viruses induce apoptosis at late stages of replication, providing a
mechanism for dissemination of progeny virus.
Apoptotic changes in Herpesvirus‐infected cells had been
documented for several herpesviruses [Delhon et al., 2002; Pagnini
et al., 2005; Gardell et al., 2006; Odeberg et al., 2006; Longo
et al., 2009; Brazeau et al., 2010], in the present studywe described the
mechanism of cell death in a neuroblastoma cell line in order to
investigate on the apoptotic process induced by CpHV‐1 during
infection.
In a ﬁrst series of experiments, we evaluated the ability of CpHV‐1
to induce apoptosis using ApoTox‐Glo™Triplex assay. These experi-
ment, allowed us to determine the viability, the citotoxicity and the
activation of caspase 3 in Neuro 2A cell line. The cytotoxicity of
CpHV‐1 infected cells increased signiﬁcantly in a time dependent
manner and the viability of infected cells signiﬁcantly decreased
respect to untreated control cells inducing apoptosis at 24 and 48 h p.
i. (Fig. 1).
Thus, we clariﬁed the apoptotic pathway in Neuro 2A cells by RT2
Proﬁler PCR microarray and by Western blot analysis providing
evidence that CpHV‐1 induces apoptotic cell death in vitro, involving
both initiators and effectors caspases.
Our data indicate that CpHV‐1 triggers apoptosis in neuronlike
cells and that this process occurs rapidly after infection. Indeed, in
these cells an over expression of pro‐apoptotic genes like Cradd, Fas,
and TNF occurred starting from 6h post‐infection.
Cradd is a death domain (DD)‐containing adaptor/signaling
molecule that promotes apoptosis. It has a dual‐domain structure
similar to that of FADD, a NH2‐terminal caspase homology
domain that interacts with caspase‐2 and a C‐terminal DD that
interacts with receptor‐interacting protein RIP. Cradd recruits
caspases and induces the activation of the apoptosis cascade [Ahmad
et al., 1997].
At 12 and 24 h post‐infection we have found that CpHV‐1
infection triggered activation of caspases genes, in particolar caspase
8, which conﬁrm the involvement of death receptor. Furthermore, at
24 h post‐infection, Western blot analysis, showed the presence of
caspase 9, 8, and 3.
Triggering of apoptosis and downstream caspases activation
can be initiated through two main pathways. The “intrinsic
or mitochondrial pathway” involves changes in mitochondrial
membrane permeability that are regulated by a family of Bcl‐
2‐related proteins. Activated proapoptotic members of this
group (Bax, Bad, Bok) form pores in the mitochondrial
membrane and promote leakage of apoptotic factors sequestered
by the mitochondria, such as cytochrome c and Smac/DIABLO,
which was overexpressed at 12 h p.i. (Table III), and is directly
linked to permeability of the organelle outer membrane
[Epand et al., 2002; Annis et al., 2005]. Loss of the mitochondrial
membrane integrity and cytochrome c release result in
apoptosome formation and processing of procaspase‐9 followed
by downstream activation of executioner caspase‐3 [Jiang and
Wang, 2004].
TABLE V. Genes Over‐ and Under‐Expressed at 48 h Post‐Infection by CpHV‐1
Symbol Description
Fold
change Symbol Description
Fold
change
Aifm1 Apoptosis‐inducing factor, mitochondrion‐associated 1 2.0531 Casp9 Caspase 9 2.013
Akt1 Thymoma viral proto‐oncogene 1 2.0509 Cd40 CD40 antigen 4.9025
Anxa5 Annexin A5 4.3591 Cd70 CD70 antigen 4.4661
Bax Bcl2‐associated X protein 5.5601 Cidea Cell death‐inducing DNA fragmentation factor, alpha
subunit‐like effector A
4.8141
Bcl10 B‐cell leukemia/lymphoma 10 4.9081 Cradd CASP2 and RIPK1 domain containing adaptor with death
domain
58.7839
Bcl2 B‐cell leukemia/lymphoma 2 16.0066 Dapk1 Death associated protein kinase 1 3.7831
Bcl2l1 BCL2‐like 11 (apoptosis facilitator) 6.1211 Diablo Diablo homolog (Drosophila) 6.1211
Birc5 Baculoviral IAP repeat‐containing 5 3.0134 Mapk1 Mitogen‐activated protein kinase 1 7.4227
Bnip2 BCL2/adenovirus E1B interacting protein 2 6.1211 Mcl1 Myeloid cell leukemia sequence 1 10.4372
Bnip3 BCL2/adenovirus E1B interacting protein 2 6.1211 Nme5 Non‐metastatic cells 5, protein expressed in (nucleoside‐
diphosphate kinase)
2.4022
Bnip3l BCL2/adenovirus E1B interacting protein 3‐like 3.7832 Polb Polymerase (DNA directed), beta 2.2492
Casp14 Caspase 14 2.8301 Tnfrsf1a Tumor necrosis factor receptor superfamily, member 1a 2.7313
Casp2 Caspase 2 4.5538 Tnfsf10 Tumor necrosis factor (ligand) superfamily, member 10 2.4444
Casp3 Caspase 3 4.7171 Traf2 Tnf receptor‐associated factor 2 3.3169
Casp4 Caspase 4 6.1211 Trp53bp2 Transformation related protein 53 binding protein 2 5.0888
Casp7 Caspase 7 6.1211
Api5 Apoptosis inhibitor 5 2.7489 Dad1 Defender against cell death 1 2.2515
Atf5 Activating transcription factor 5 4.8525 Dffb DNA fragmentation factor, beta subunit 2.6478
Bcl2l2 Bcl2‐like 1Bcl2‐like 2 2.6165 Fas Fas (TNF receptor superfamily member 6) 2.8243
Bid BH3 interacting domain death agonist 2.6999 Gadd45a Growth arrest and DNA‐damage‐inducible 45 alpha 2.3895
Birc2 Baculoviral IAP repeat‐containing 2 3.6729 Lhx4 LIM homeobox protein 4 3.7444
Birc3 Baculoviral IAP repeat‐containing 3 2.3721 Ltbr Lymphotoxin B receptor 2.3913
Bok BCL2‐related ovarian killer protein 2.3496 Pycard PYD and CARD domain containing 3.2115
Casp6 Caspase 6 2.0995 Ripk1 Receptor (TNFRSF)‐interacting serine‐threonine kinase 1 2.5729
Casp8 Caspase 8 2.068 Tnfsf12 Tumor necrosis factor (ligand) superfamily, member 12 2.3227
Cideb Cell death‐inducing DNA fragmentation factor, alpha
subunit‐like effector B
2.9094 Xiap X‐linked inhibitor of apoptosis 3.8246
Regulated genes with fold change2.0 (either up or down) and P‐values of0.05 are presented, expressed in Neuro 2A cell line infected with CpHV‐1 (MOI 1) at 48 h post‐
infection are presented.
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The overexpression of caspases, FasL, and TNF receptor family
genes at 6 and 12 h post‐infection suggest that the induction of
apoptosis by CpHV‐1 infection also involves the extrinsic pathway.
The over expression of FasL gene indicates that caspase‐8
activation in CpHV‐1‐infected neuronal cells can be mediated by
Fas/FasL signal payhway. However, just how FasL expression is
regulated by CpHV‐1 remains unclear, and further studies are under
way to elucidate the mechanism of FasL regulation in CpHV‐1‐
infected MDBK cells.
These data are conﬁrmed by Western blot assay, in fact we have
found at 12 and 24 h post‐infection a signiﬁcant increase of caspase
8, 9, and 3.
Our data agree with results of Gautier et al. [2003] who described
induction of apoptosis in neuronlike cells infected with HSV‐1 at
early stage of infections, with the results of Xu et al. [2012] which
reported similar ﬁndings for BHV‐1 infection in MDBK cell line and
with several studies that reported concomitant caspase‐8 and
caspase‐9 activation in various apoptotic systems [Aubert et al.,
2007; St‐Louis and Archambault, 2007; Fiorito et al., 2008; Longo
et al., 2009].
In fact, at 12h post‐infection the gene proﬁle showed an over
expression of genes that play an important role in intrinsic and
extrinsic pathways of apoptosis like caspase 8 gene, Apaf1 that activates
caspase 9, Bax, Bad, Bok, Bcl10 that encode for a protein caspase
recruitment domain (CARD) and have been shown to induce apoptosis
and to activate NF‐kappaB, Card10, Dapk1, Polb, Diablo, and the other
caspases genes.
In our study the levels of p53 protein and p53 phosphorylation
increased after infection, suggesting that p53 plays a role in CpHV‐1‐
induced apoptosis. Genes that are regulated by p53 (like Bax, e.
g.) were also induced in a p53‐dependent fashion. It has been
demonstrated that the cleavage of p53 occurs in response to
DNA damage, generating p50 or p40 [Molinari et al., 1996], and
consequently alters the transcriptional regulatory activity of
p53 [Hupp et al., 1992; Horikoshi et al., 1995; Chen et al., 1996].
Several other herpesviruses such as HSV‐1, HSV‐2, and BHV‐1
Fig. 2. Caspases activation is induced in Neuro 2A cells infected with CpHV‐1. Replicate cultures of Neuro 2A cells were mock infected or infected with inoculum consisting of
criolysated infected Neuro 2A cells. Inoculum had been titrated in advance, and the multiplicity of infection was approximately 1. At different time points after infection, cells
were scraped, harvested, lysate, and subjected toWestern blot analysis with antibodies against Caspase 8, 9, and 3. Actin protein levels were detected to ensure equal protein loading
(A). Densitometric analysis of blots relative to Caspase 8, 9, and 3 (B, C, and D). Results are expressed as the mean SD of three separate experiments, a P‐value<0.05 was selected
as signiﬁcant.
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Fig. 3. CpHV‐1 upregulates Bcl‐2 and phospho‐Bcl‐2. Replicate cultures of Neuro 2A cells were mock infected or infected with inoculum consisting of criolysated infected Neuro
2A cells. Inoculum had been titrated in advance, and the multiplicity of infection was approximately 1. At different time points after infection, cells were scraped, harvested, lysate,
and subjected to Western blot analysis with antibodies against actin, Bcl‐2 and phospho‐Bcl‐2. Actin protein levels were detected to ensure equal protein loading (A).
Densitometric analysis of blots relative to Bcl‐2 and phospho‐Bcl‐2 (B and C). Results are expressed as the mean SD of three separate experiments, a P‐value<0.05 was selected
as signiﬁcant.
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induce DNA damage after infection [Schlehofer and Hausen, 1982;
Pilon et al., 1986; Devireddy and Jones, 1999], suggesting that
also infection by CpHV‐1 can leads to DNA damage and p53
induction.
In our study the levels of Bcl‐2 protein and its phosphorylated form
increased after infection which is surprising due to the antiapoptotic role
of Bcl‐2 protein [Gross et al., 1999]. Simultaneous increase of Bcl‐2 and
phospho Bcl‐2 at 12h post‐infection, preceded by an increase of
Fig. 4. CpHV‐1 upregulate p53 and phospho‐p53. Replicate cultures of Neuro 2A cells were mock infected or infected with inoculum consisting of criolysated infected Neuro 2A
cells. Inoculum had been titrated in advance, and the multiplicity of infection was approximately 1. At different time points after infection, cells were scraped, harvested, lysate, and
subjected to Western blot analysis with antibodies against actin, p53, and phospho‐p53. Actin protein levels were detected to ensure equal protein loading (A). Densitometric
analysis of blots relative to p53 and phospho‐p53 (B and C). Results are expressed as the mean SD of three separate experiments, a P‐value <0.05 was selected as signiﬁcant.
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phospho‐p53 at 6h post‐infection suggest that the induction of apoptosis
by CpHV‐1 infection involves also the extrinsic pathway.
Bcl‐2 protein is normally expressed in a wide range of tissues and is
required for normal development and maintenance of the immune
system [Veis et al., 1993].
The function of cellular Bcl‐2 family members is regulated in part by
caspases. Bellows and others have reported that caspase‐3 cleaves Bcl‐2
at Asp‐34 and Bcl‐xL at Asp‐61 and Asp‐76 to produce N‐terminally
truncated proteins that have lost their antiapoptotic activities [Cheng et
al., 1997; Clem et al., 1998; Fujita et al., 1998; Grandgirard et al., 1998;
Kirsch et al., 1999; Bellows et al., 2000]. These cleavages are likely to be
physiologically signiﬁcant, as mutation of the cleavage sites in Bcl‐2
and Bcl‐xL enhances their antiapoptotic activities [Cheng et al., 1997;
Clem et al., 1998]. The caspase cleavage products of Bcl‐2 and Bcl‐xL
are potently proapoptotic, based on transfection studies expressing
protein fragments that are equivalent to caspase cleavage products
[Cheng et al., 1997; Clem et al., 1998]. Thus, the generation of these
fragments inside cells may accelerate cell death by amplifying the
caspase cascade and in support of this hypothesis, it has been
demonstrated that N‐terminally truncated Bcl‐2 triggers the release of
cytochrome c from mitochondria, similar to Bax [Jurgensmeier et al.,
1998; Kirsch et al., 1999].
In conclusion, the simultaneous activation of caspase‐8 and
caspase‐9 suggests that CpHV‐1 can trigger the death‐receptor
pathway and the mitochondrial pathway separately and in parallel. It
will be interesting to reveal the upstream signals that trigger these two
pathways following CpHV‐1 infection.
Our ﬁndings are signiﬁcant because this is the ﬁrst published study
showing the effect of CpHV‐1 infection in neuronal cells in terms of
gene expression and apoptosis modulation.
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